首页> 中文期刊> 《中德临床肿瘤学杂志(英文版) 》 >乳腺癌干细胞多药耐药基因的表达及意义

乳腺癌干细胞多药耐药基因的表达及意义

         

摘要

Objective:To approach the expressions of MDR1 and BCRP in breast cancer stem cells and differentiated cells.Methods:The breast cancer stem calls were separated from human breast cancer primary tissues and MCF-7 by flow cytometry.Then we measured the expressions of MDR1 and BCRP with different subset cells by Realtime-PCR.Results:Contrasted with breast cancer differentiated cells,the expressions of MDR1 and BCRP in breast cancer stem calls were higher (P<0.01),and the proportion of stem cells rose after chemotherapy (P<0.01).Conclusion:Contrasted with breast cancer differentiated cells,breast cancer stem cells have stronger ability of clrug-resistanca with higher level of multi-drug resistance genes,and it is one of key points for chemotherapy failure of breast cancer.

著录项

  • 来源
    《中德临床肿瘤学杂志(英文版) 》 |2008年第009期|538-541|共4页
  • 作者单位

    Department of Breast and Thyroid Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;

    Department of Breast and Thyroid Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;

    Department of Breast and Thyroid Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;

    Department of Breast and Thyroid Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;

    Department of Breast and Thyroid Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学 ;
  • 关键词

    stem cell; breast cancer; chemotherapy; multi-drug resistance;

    机译:干细胞;乳腺癌;化疗;多种耐药性;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号